Biofrontera Inc. aksje
BFRI
After-hours$0.9542+0.0682 (+7.70%)
Post-Market:$0.9800+0.03 (+2.70%)
Laster graf...
Biofrontera Inc.
Market Cap
$12,216,951
Åpning0.8990
Høy0.9600
Lav0.8746
Volum224.39k
P/EN/A
Markedsverdi12.22M
52-ukers høy1.1900
52-ukers lav0.5530
Gj.sn. volum168.86k
UtbytteN/A
Beta0.91
EPS-0.9800
Om Biofrontera Inc. aksje
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Selskapsinformasjon
Børs: NasdaqCM (NCM)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
660 Main Street
01801 Woburn, United States
01801 Woburn, United States
Telefon: + 781 245 1325
Nettside: https://www.biofrontera-us.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Anbefaling:1.00 - Stærk køb
Laveste kursmål
2.75
↑ 188.2%
Gjennomsnittlig kursmål
5.88
↑ 515.7%
Median kursmål
5.88
↑ 515.7%
Høyeste kursmål
9.00
↑ 843.2%